Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5 -trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-yla mino)- benzamide

Details for Australian Patent Application No. 2010241419 (hide)

Owner Novartis AG

Inventors Brozio, Jorg; Sutton, Paul Allen; Manley, Paul W.; Karpinski, Piotr H.; Wu, Raeann; Monnier, Stephanie; Shieh, Wen-Chung

Agent Davies Collison Cave

Pub. Number AU-B-2010241419

Parent 2006276205

Filing date 12 November 2010

Wipo publication date 2 December 2010

Acceptance publication date 29 March 2012

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 December 2010 Application Open to Public Inspection

  Published as AU-B-2010241419

2 December 2010 Complete Application Filed

29 March 2012 Application Accepted

  Published as AU-B-2010241419

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010241420-Foam port device having closed-end lumens

2010241418-Functional layers of biomolecules and living cells, and a novel system to produce such